Nuwellis, Inc. (NUWE)
NUWENASDAQ-CMBiotechnology: Electromedical & Electrotherapeutic Apparatus
$5.10
+0.1600 (+3.24%) today
At the close, Nov 10, 4:00 PM ET. After hours $5.10 -2.67%
- Market cap
- $2.12m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $4.87 to $5.31
- 52-week range
- $2.52 to $1,555.87
- Average volume
- 983.5k
- Previous close
- $4.94
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $2.22m | $2.42m | $2.40m | $1.97m |
| Gross profit | $1.45m | $1.65m | $1.68m | $1.50m |
| Operating income | -$2.70m | -$2.44m | -$4.57m | -$3.17m |
| Net income | $468.0k | -$2.42m | -$4.54m | -$4.83m |
Last four quarters: revenue $9.01m, margin -125.6%, free cash flow -$12.59m
News
8 latest- Nuwellis Submits FDA Application To Expand Aquadex Use In Pediatric Patients RTTNews · 5 days ago
- Nuwellis To Implement 1-for-9 Reverse Stock Split; Stock Down RTTNews · Oct 28, 2026
- Nuwellis, Inc. Announces one-for-nine Reverse Stock Split Effective October 26, 2026Fintel · Oct 23, 2026
- Nuwellis Appoints Brian Johnson As Director Of Quality And Regulatory Affairs RTTNews · Sep 17, 2026
- Top Biotech Gainers: GCTK On The Move, BHC, CORT Boost FY'26 Outlook, NEOG On Watch RTTNews · Jul 30, 2026
- Nuwellis Study Acceptance Highlights Aquadex In Pediatric Care, Stock Rockets In Pre-Market RTTNews · Jul 30, 2026
- Top Biotech Gainers: NXTC Soars On Merger Deal, BMGL Moves Past Nasdaq Woes, OTLK Awaits FDA Verdict RTTNews · Jul 14, 2026
- Nuwellis (NUWE) Q1 2026 Earnings TranscriptThe Motley Fool · May 12, 2026
The company
Nuwellis, Inc. (Nasdaq: NUWE) is a medical technology company committed to delivering solutions for patients with cardiorenal conditions. The Company develops solutions designed to support patient care through monitoring, therapy, and data-informed clinical decision-making across acute and chronic care settings. Nuwellis' strategy includes expanding its portfolio through internally developed technologies and strategic commercial partnerships that broaden its presence across acute and chronic critical care.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- nuwellis.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.